- Nature | Algorithm for Optimized mRNA Design Improves Stability and Immunogenicity (202305)
- PNAS | A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry (202110)
- Nature Computational Science | Generative aptamer discovery using RaptGen (202206)
- Review | The Progress and Promise of RNA Medicine─ An Arsenal of Targeted Treatments (202205)
- Review | Methods and applications of in silico aptamer design and modeling (202011)
- Review | Computational predictive approaches for interaction and structure of aptamers (202007)
- Science | Distinct allosteric mechanisms of first-generationMsbA inhibitors (202109)
- JCIM | Research and Evaluation of the Allosteric Protein-Specific Force Field Based on a Pre-Training Deep Learning Model (202304)
- Nature | Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor (202003)
- Science | Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir (202006)
- Nat Chem Biol | Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection (202305)
- JMC | Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity (202209)
- Viruses | Antiviral Drug Discovery for the Treatment of COVID-19 Infections (202205)
- JCIM | High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor (202111)
- JMC | Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (202108)